The efficacy of liposomal amphotericin B and voriconazole was evaluated against the systemic infection by Fusarium oxysporum species complex or Fusarium keratoplasticum. Although MIC values were within the epidemiological cutoff values (ECVs) recently stablished for Fusarium spp., no efficacy was obtained, indicating that ECVs for Fusarium are not relevant for in vivo efficacy.
Keywords: Animal model; Antifungal therapy; Fusariosis; Fusarium; Liposomal amphotericin B; Voriconazole.
Copyright © 2018 Elsevier Inc. All rights reserved.